Adenoid cystic carcinomas (AdCC) of salivary gland origin have long been categorized as fusion-defined carcinomas owing to the almost universal presence of the gene fusion MYB::NFIB , or less commonly MYBL1::NFIB. Sinonasal AdCC is an aggressive salivary gland malignancy with no effective systemic therapy. Therefore, it is urgent to search for potentially targetable genetic alterations associated with AdCC. We have searched the authors' registries and selected all AdCCs arising in the sinonasal tract. The tumors were examined histologically, immunohistochemically, by next generation sequencing (NGS) and/or fluorescence in situ hybridization (FISH) looking for MYB/MYBL1 and/or NFIB gene fusions or any novel gene fusions and/or mutations. In addition, all tumors were tested for HPV by genotyping using (q)PCR. Our cohort comprised 88 cases of sinonasal AdCC, predominantly characterized by canonical MYB::NFIB (49 cases) and MYBL1::NFIB (9 cases) fusions. In addition, noncanonical fusions EWSR1::MYB ; ACTB::MYB; ESRRG::DNM3 , and ACTN4::MYB were identified by NGS, each of them in 1 case. Among nine fusion-negative AdCCs, FISH detected rearrangements in MYB (7 cases) , NFIB (1 case), and EWSR1 (1 case). Six AdCCs lacked fusions or gene rearrangements, while 11 cases were unanalyzable. Mutational analysis was performed by NGS in 31/88 (35%) AdCCs. Mutations in genes with established roles in oncogenesis were identified in 21/31 tumors (68%), including BCOR (4/21; 19%), NOTCH1 (3/21; 14%), EP300 (3/21; 14%), SMARCA4 (2/21; 9%), RUNX1 (2/21; 9%), KDM6A (2/21; 9%), SPEN (2/21; 9%), and RIT1, MGA, RB1, PHF6, PTEN, CREBBP, DDX41, CHD2, ROS1, TAF1, CCD1, NF1, PALB2, AVCR1B, ARID1A, PPM1D, LZTR1, GEN1 , PDGFRA , each in 1 case (1/21; 5%). Additional 24 cases exhibited a spectrum of gene mutations of uncertain pathogenetic significance. No morphologic differences were observed between AdCCs with MYBL1::NFIB and MYB::NFIB fusions. Interestingly, mutations in the NOTCH genes were seen in connection with both canonical and noncanonical fusions, and often associated with high-grade histology or metatypical phenotype, as well as with poorer clinical outcome. Noncanonical fusions were predominantly observed in metatypical AdCCs. These findings emphasize the value of comprehensive molecular profiling in correlating morphologic characteristics, genetic landscape, and clinical behavior in AdCC.

Bioptic Laboratory Ltd

Consultoria em Patologia Botucatu São Paulo Brazil

Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Erlangen Erlanden

Department of Pathology and Laboratory Medicine The University of Kansas Medical Center Kansas City KS

Department of Pathology and Molecular Pathology University Hospital Zurich Zurich Switzerland

Department of Pathology Charles University Faculty of Medicine in Pilsen

Department of Pathology Medical University of Vienna Vienna Austria

Department of Pathology Tenon Hospital Sorbonne University Paris France

Departments of Otorhinolaryngology

Dermpath Muenchen Germany

Institute of Biomedicine Pathology University of Turku Turku Finland

Institute of Pathology University Hospital Erlangen Friedrich Alexander University Erlangen Nürnberg

Molecular and Genetic Laboratory Bioptic Laboratory Ltd Pilsen

Pathology Turku University Hospital

Service d'Anatomo Pathologie Department of Pathology Hôpital Européen G Pompidou APHP Université de Paris

The Fingerland Department of Pathology Charles University Faculty of Medicine and University Hospital Hradec Kralove Hradec Kralove Czech Republic

The University of Kansas School of Medicine

Zobrazit více v PubMed

WHO Classification of Tumours Editorial Board . Head and Neck Tumours. Lyon, France: International Agency for Research on Cancer. forthcoming (WHO classification of tumours series, 5th ed.; vol. 9) https://publications.iarc.fr

Persson M, Andren Y, Mark J, et al. . Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–18744. PubMed PMC

Fujii K, Murase T, Beppu S, et al. . MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma. Histopathology. 2017;71:823–834. PubMed

Persson M, Andren Y, Moskaluk CA, et al. . Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma. Genes Chromosomes Cancer. 2012;51:805–817. PubMed

Šteiner P, Andreasen S, Grossmann P, et al. . Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands. Virchows Arch. 2018;473:471–480. PubMed

Skálová A, Klubíčková N, Bradová M, et al. . Discovery of novel TULP4/ACTN4/EWSR1/ACTB::MYB and ESRRG::DNM3 fusions expands molecular landscape of adenoid cystic carcinoma beyond fusions between MYB/MYBL1 and NFIB genes. Am J Surg Pathol. 2024;48:1503–1511. PubMed PMC

Bjørndal K, Krogdahl A, Therkildsen MH, et al. . Salivary adenoid cystic carcinoma in Denmark 1990-2005: outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol. 2015;51:1138–1142. PubMed

Mauthe T, Holzmann D, Soyka MB, et al. . Overall and disease-specific survival of sinonasal adenoid cystic carcinoma: a systematic review and meta-analysis. Rhinology. 2023;61:508–518. PubMed

Suárez C, Barnes L, Silver CE, et al. . Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: a collective international review. Auris Nasus Larynx. 2016;43:477–484. PubMed PMC

Kawakita D, Murase T, Ueda K, et al. . The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan. Int J Clin Oncol. 2020;25:1774–1785. PubMed

Cavalieri S, Mariani L, Vander Poorten V, et al. . Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands. Eur J Cancer. 2020;136:35–42. PubMed

Trope M, Triantafillou V, Kohanski MA, et al. . Adenoid cystic carcinoma of the sinonasal tract: a review of the national cancer database. Int Forum Allergy Rhinol. 2019;9:427–434. PubMed

Ho AS, Kannan K, Roy DM, et al. . The mutational landscape of adenoid cystic carcinoma. Nat Genet. 2013;45:791–798. PubMed PMC

Ho AS, Ochoa A, Jayakumaran G, et al. . Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma. J Clin Invest. 2019;129:4276–4289. PubMed PMC

Xie M, Wei S, Wu X, et al. . Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival. Lung Cancer. 2018;121:41–47. PubMed

Ferrarotto R, Heymach JV. Taking it up a NOTCH: a novel subgroup of ACC is identified. Oncotarget. 2017;8:81725–81726. PubMed PMC

Ferrarotto R, Mitani Y, Diao L, et al. . Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors. J Clin Oncol. 2017;35:352–360. PubMed PMC

Mathew EP, Todorovic E, Truong T, et al. . Metatypical adenoid cystic carcinoma: a variant showing prominent squamous differentiation with a predilection for the sinonasal tract and skull base. Am J Surg Pathol. 2022;46:816–822. PubMed

Weinreb I, Rooper LM, Dickson BC, et al. . Adenoid cystic carcinoma with striking tubular hypereosinophilia: a unique pattern associated with nonparotid location and both canonical and novel EWSR1::MYB and FUS::MYB fusions. Am J Surg Pathol. 2023;47:497–503. PubMed

Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands; a correlation of histologic features and clinical course. Cancer. 1978;42:265–282. PubMed

Szanto PA, Luna MA, Tortoledo ME, et al. . Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54:1062–1069. PubMed

Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg. 1974;128:512–520. PubMed

van Weert S, van der Waal I, Witte BI, et al. . Histopathological grading of adenoid cystic carcinoma of the head and neck: analysis of currently used grading systems and proposal for a simplified grading scheme. Oral Oncol. 2015;51:71–76. PubMed

Landrum MJ, Lee JM, Benson M, et al. . ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067. PubMed PMC

Koboldt DC. Best practices for variant calling in clinical sequencing. Genome Med. 2020;12:91–104. PubMed PMC

Michal M, Berry RS, Rubin BP, et al. . EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic/myofibroblastic neoplasms. Am J Surg Pathol. 2018;42:1325–1333. PubMed

van Dongen JJ, Langerak AW, Bruggemann M, et al. . Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257–2317. PubMed

Kazakov DV, Nemcova J, Mikyskova I, et al. . Human papillomavirus in lesions of anogenital mammary-like glands. Int J Gynecol Pathol. 2007;26:475–480. PubMed

Hagmar B, Johansson B, Kalantari M, et al. . The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother. 1992;9:113–117. PubMed

Altemani A, Costa AF, Montalli VA, et al. . Signet-ring cell change in adenoid cystic carcinoma: a clinicopathological and immunohistochemical study of four cases. Histopathology. 2013;62:531–542. PubMed

Michal M, Skálová A, Hyrcza M, et al. . Nasal and sinonasal tumors formed by atypical adenomatous lesions arising in respiratory epithelial adenomatoid hamartoma/seromucinous hamartoma. Virchows Arch. 2024;485:31–42. PubMed

Mitani Y, Rao PH, Futreal PA, et al. . Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011;17:7003–7014. PubMed PMC

Bradova M, Costes-Martineau V, Laco J, et al. Sinonasal adenosquamous carcinomas arising in seromucinous hamartoma or respiratory epithelial adenomatoid hamartoma with atypical features: report of 5 detailed clinicopathologic and molecular characterization of rare entity. Histopathology. 2024. doi: 10.1111/his.15369. Epub ahead of print.. PubMed DOI PMC

Stephens PJ, Davies HR, Mitani Y, et al. . Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest. 2013;123:2965–2968. PubMed PMC

Ross JS, Wang K, Rand JV, et al. . Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies. Am J Surg Pathol. 2014;38:235–238. PubMed

Aster JC, Blacklow SC. Targeting the Notch pathway: twists and turns on the road to rational therapeutics. J Clin Oncol. 2012;30:2418–2420. PubMed

Agrawal N, Frederick MJ, Pickering CR, et al. . Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154–1157. PubMed PMC

Rettig EM, Chung CH, Bishop JA, et al. . Cleaved NOTCH1 expression pattern in head and neck squamous cell carcinoma is associated with NOTCH1 mutation, HPV status, and high-risk features. Cancer Prev Res (Phila). 2015;8:287–295. PubMed PMC

Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011;11:338–351. PubMed

Kagawa S, Natsuizaka M, Whelan KA, et al. . Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. Oncogene. 2015;34:2347–2359. PubMed PMC

Miller LE, Au V, Mokhtari TE, et al. . A contemporary review of molecular therapeutic targets for adenoid cystic carcinoma. Cancers (Basel). 2022;14:992. PubMed PMC